Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-020640

Options or other derivatives

  • SVP, Diagnostics, immunoSEQ Dx acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Palaniappan Jyoti SVP, Diagnostics, immunoSEQ Dx 2020-03-19 Grant or award · Stock Option (Right to Buy) +125,000 125,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…